Egypt detects 841 new coronavirus cases; 42 deaths on Friday    'Once-in-a-lifetime' Maradona World Cup jersey hits auction block    Egypt coach admits Trezeguet's injury is 'big loss'    Man City's Foden dumps social media company over Mbappe tweet    Kremlin to expel 10 US diplomats in response to US sanctions    Iran nuclear chief Salehi says 60% enrichment has started at Natanz site    At least 21 African migrants die as boat sinks off Tunisia    Finland to open restaurants, give more COVID-19 vaccine to heavily hit areas    WHO chief says COVID-19 infection rate approaching highest of pandemic so far    Sisi stresses to Djibouti president importance of reaching GERD settlement to avoid regional instability    We will resort to international community after all GERD negotiations finish: Egypt FM    President Sisi supports Eni expanding operations in Egypt    10 emerging writers receive $50,000 Whiting Awards    J.K. Rowling children's story 'The Christmas Pig' out in October    2 crew members of impounded Ever Given allowed to return home for personal emergencies: Suez Canal Authority    15 injured as Minya Al-Qamh train derails    Skyway Development launches EGP 700bn Bayadega project at Egypt's New Capital    Turkey to send delegation to Egypt in May, its foreign minister says    Egypt condemns continued attacks by Yemen's Houthi militias towards Saudi territory    SODIC hires Hermes to study acquisition offer by Aldar Properties    Egyptian President approves €1.88bn loan for monorail lines    Veteran Egyptian journalist Makram Mohamed Ahmed passes away at 86    EFG Hermes determines fair value of Arab Investment Bank at EGP1.1bln    Al Ahly get ready for fierce league clash against Zamalek    Fans allowed at opening match of UEFA EURO 2020: Italy    Egypt halts traditional amateur football tournaments during Ramadan    Egypt Press Syndicate condemns Health Ministry's alleged media obstruction    EU, EIB, MSMEDA inspect Community Development Programme projects in Port Said    Egypt tourism minister discusses preparations for upcoming Arabian Travel Market with UAE    Egypt PM follows up on progress of Decent Life rural development initiative    Egypt, Turkey eye new phase of bilateral relations    Claims that Ancient Egyptians were African untrue: Zahi Hawass    New evidence suggests gender-based labour division as farming spread in Europe    Egyptian Armed Forces continue sterilisation at major mosques during Ramadan    Iftar Cannon: History behind special Ramadan tradition in Egypt    Egypt, Arab League, UN discuss developments in Libya    Sudan invites Egypt, Ethiopia to closed meeting on GERD    Egyptian farmers fearful as Ethiopia goes for 2nd Blue Nile dam filling    Nile tensions spill over    Party consensus    Russian FM says Egypt is main partner in Middle East, Africa    Egypt sees an uptick in new coronavirus infections registers 801 new cases on Saturday    PMI moves towards a smoke-free transformation, takes part in a webinar on e-cigarettes    Allianz Egypt partners with IGNITE to equip brand ambassadors for 2021 Olympics    Hassan Allam consortium wins contract to manage, operate Grand Egyptian Museum    Enhanced Labs signs Mr. Olympia 2020 "Big Ramy" And His Trainer Dennis James    King Tutankhamun funerary mask is must-see tourist icon: The Telegraph    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





GlaxoSmithKline in talks with Hikma to sell Egypt stake, rules out talks with Rameda
Published in Amwal Al Ghad on 08 - 02 - 2021

GlaxoSmithKline will focus its efforts and resources on discussing the sale of its stake in Egypt with Hikma Pharmaceuticals, said GlaxoSmithKline Egypt (GSK Egypt) in a bourse filling on Monday.
The company added that it was not in a position to start negotiations with Rameda or other parties on the potential sale in the current time. It attributed its decision to the fact that the diligence and negotiation would consume "significant resources and time from the Majority Shareholder."
It also clarified that it wishes "to minimise disruption to the business of GlaxoSmithKline S.A.E. and to ensure the continued supply of medicines, vaccines and consumer products in Egypt."
The announcement came in response to Rameda's letter expressing interest to buy Glaxo Group Limited's majority stake in GSK Egypt.
Glaxo (GSK) described the potential transaction as "complex" as it is considering selling its shareholding in GlaxoSmithKline Egypt only as part of a comprehensive sale of the pharma and consumer businesses in Egypt – including operations that sit outside the listed entity – and its pharma business in Tunisia.
For these reseaons, Glaxo decided "to focus its efforts and resources on discussing a transaction with Hikma Pharmaceuticals at this time." It added that it appreciates Rameda's interest, but Glaxo is not "in a position to engage with Rameda on discussing a potential transaction at this time."
In January, Hikma announced plans to acquire GlaxoSmithKline's stake in some assets including the drugmaker's pharmaceutical, consumer commercialisation, and manufacturing business in Egypt and its drugs business in Tunisia.
A day later, GSK Egypt said in a bourse filling that its board of directors has allowed Hikma to undertake due diligence, revealing that Glaxo had signed a non-binding term sheet with Hikma for the potential sale of its entire stake of 91.2 percent in GSK Egypt.


Clic here to read the story from its source.